Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Atorvastatin (Primary) ; Chenodeoxycholic acid (Primary) ; Resveratrol
- Indications Paraplegia
- Focus Therapeutic Use
- Acronyms SPA-M
- 30 Mar 2018 Status changed from active, no longer recruiting to completed.
- 03 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Feb 2016 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.